Logo

Delfi Diagnostics: Jessica Meng

Jul 12, 2022

Delfi Diagnostics has hired Jessica Meng as its first chief commercial officer. Meng has over 20 years of experience in healthcare, as well as extensive product launch leadership. She most recently led the women's health division of Myovant Sciences as general manager and VP of sales and marketing. Prior to Myovant, she was VP of marketing for Veracyte, launching multiple genomic diagnostic products in oncology and pulmonology. Meng has also held commercial leadership roles at Genentech, most notably leading the marketing of Genentech's Avastin.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.